Home > News > featured news > Endo Announces Fill-Finish Manufacturing Agreement with U.S. Government to Support Production of Critical Medicines

GOVERNMENT BUSINESS

Endo Announces Fill-Finish Manufacturing Agreement with U.S. Government to Support Production of Critical Medicines

Endo | November 20, 2021

Endo International plc today announced that its subsidiary, Par Sterile Products, LLC (Par Sterile), has entered into a cooperative agreement to expand its sterile fill-finish manufacturing production capacity and capabilities at its Rochester, Michigan plant to support the U.S. government's national defense efforts regarding production of critical medicines advancing pandemic preparation.

Under the terms of the agreement, Par Sterile's Rochester facility will establish a new sterile fill-finish manufacturing asset capable of processing liquid or lyophilized products requiring Biosafety Level (BSL) 2 containment. It will also provide expanded product inspection and packaging capacity as well as sterile fill-finish manufacturing services to the U.S. Government. Under the terms of the agreement, the U.S. government will fund approximately $90 million of the program's total expected cost of approximately $120 million.

"Endo strives to be a force for good, and we are proud to partner with the U.S. government in its efforts to expand and accelerate domestic manufacturing in support of future pandemic preparedness. This collaboration underscores our longstanding history as a U.S. manufacturer of high-quality medicines."

Blaise Coleman, President and CEO of Endo

The agreement is a result of efforts defined under the Defense Production Act to address vulnerabilities in critical product supply chains and strengthen the advancement of manufacturing and on-shoring of domestic essential medicines production.

The Department of Defense's Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) Joint Assisted Acquisition team in partnership with Army Contracting Command– Aberdeen Proving Ground (ACC - APG) – COVID Response are the awarding and administering acquisition offices. This work was supported by the ACC - APG – COVID Response, under the authority of 31 U.S.C. 6305 pursuant to Section 3101 of the American Rescue Plan Act (Public Law 117-2) and Title III of the Defense Production Act of 1950 (50 U.S.C. 4533) under Award No. W58P05-22-2-0001. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the JPEO-CBRND or ACC – APG – COVID Response.

About Endo
Endo is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Our decades of proven success come from passionate team members around the globe collaborating to bring the best treatments forward. Together, we boldly transform insights into treatments benefiting those who need them, when they need them.

Spotlight

More featured news

Spotlight

Related News

EMERGING TECHNOLOGY, CYBERSECURITY

Acalvio with Carahsoft to Expand Cybersecurity Solutions in Public Sector

Acalvio Technologies | March 13, 2023

One of the leaders in cyber deception, Acalvio Technologies and The Trusted Government IT Solutions Provider®, Carahsoft Technology Corp., recently announced a partnership. Carahsoft will serve as Acalvio's Master Government Aggregator®, as per the agreement, making the company's market-leading Active Defense Platform and ShadowPlex Advanced Threat Defense accessible to the Public Sector via Carahsoft reseller associates, NASA Solutions for Enterprise-Wide Procurement (SEWP) V, National Association of State Procurement Officials ValuePoint, Software 2 (ITES-SW2), Information Technology Enterprise Solutions, National Cooperative Purchasing Alliance and OMNIA Partners contracts. Acalvio's ShadowPlex enables government agencies to efficiently execute the three most important aspects of adversarial engagement, including detection, which helps in rapid discovery of adversary presence both on-premises and in–cloud infrastructure, disruption to impede and slow down attacks and intelligence to easily collect granular forensics of attacker tactics, techniques, and procedures. The Continuous Diagnostics & Mitigation (CDM) Program Approved Products List (APL) has approved Acalvio Technologies, and their products are now accessible through various Carahsoft contracts, including SEWP V contracts NNG15SC03B and NNG15SC27B, NASPO ValuePoint Master Agreement #AR2472, ITES-SW2 Contract W52P1J-20-D-0042, NCPA Contract NCPA01-86, and OMNIA Partners Contract #R191902. About Acalvio Technologies Based in Santa Clara, California, Acalvio is one of the leading cyber deception technologies providers. The company helps businesses actively defend against advanced security threats. Established in 2015, it was built on 25 issued patents in autonomous deception and advanced AI. It also offers robust solutions for Identity Threat Detection and Response (ITDR), Ransomware Protection and Advanced Threat Detection for IT and OT networks, and Zero Trust. About Carahsoft Carahsoft is a government IT solutions provider, combining technological expertise with a comprehensive understanding of the government procurement process to assist public sector organizations in selecting and implementing the most cost-effective solution. The company is based in Reston, Virginia. It is one of the largest government partner catering as the government's master aggregator for many of its best-in-class vendors. It also drives value for a vast ecosystem of IT manufacturers, system integrators, resellers, and consulting partners.

EMERGING TECHNOLOGY, INFRASTRUCTURE

Dye & Durham expands mission-critical software solutions to governments across Canada

Newswire.ca | May 03, 2023

Dye & Durham Limited, a leading provider of cloud-based, efficient workflow software for legal and business professionals, today announced a renewed partnership with CentralSquare Technologies ("CentralSquare") by entering into a 10-year agreement that significantly expands Dye & Durham's seamless integration of online government services. As a trusted public sector partner for decades, Dye & Durham provides mission-critical solutions to governments at the municipal, provincial and federal levels that deliver online services relied upon by millions of Canadians, including legal and financial services professionals. Dye & Durham is also a market leader in driving innovative digital infrastructure capabilities that enable governments to seamlessly serve Canadians. That includes providing real-time online access to tax certificates, facilitating millions of tax and bill payments between governments and the nation's largest financial institutions and acting as an authorized service provider under contract with the Government of Ontario for over 25 years. Responsibilities in the province include providing front-end electronic registry solutions and operational capabilities for the Ontario Business Registry that enables access to corporate records, registrations and filing services. Not only do these solutions help governments improve the citizen experience, they also drive significant costs savings for municipal and provincial governments by having Dye & Durham manage the entire process. Under the new 10-year agreement, more municipalities in Ontario and Alberta will now have access to Dye & Durham's TCOL (Tax Certificates Online) solution that has been available in British Columbia since 2007, where at least 108 municipalities are using it. To date, Dye & Durham has processed more than two million tax certificates. "We pride ourselves on operating Canada's digital infrastructure that enables millions of transactions that power the economy," said Matthew Proud, CEO of Dye & Durham. "That's why we're committed to constantly improving the delivery of crucial government services in a seamless manner to support economic growth and improve the government-to-citizen experience." The renewed partnership will also see further integration of CentralSquare's innovative solutions within the broader Dye & Durham technology ecosystem, driving greater efficiencies between government, businesses and citizens. "At our core, we believe in creating smart solutions that improve the lives of citizens," said Justin Murphy, VP of Product Management at CentralSquare. "Working with Dye & Durham – a like-minded company where innovation is at the heart of everything we do – has allowed us to bring additional value to our cloud-based Property Tax solution in the Ontario market, and we are thrilled to be continuing our partnership." About Dye & Durham Dye & Durham Limited is one of the world's largest providers of cloud-based legal practice management software. Dye & Durham also provides critical information services and workflows, which customers use to manage their non-discretionary information, regulatory and due diligence requirements. The company has operations in Canada, the United Kingdom, Ireland, and Australia. About CentralSquare Technologies CentralSquare Technologies is the largest independent provider of public sector software solutions that empower local and state governments to build smarter, safer and more connected communities. Over 8,000 agency customers across North America rely on CentralSquare's technology to deliver solutions ranging from computer-aided-dispatch systems, 911 and records management solutions which enhance public safety, to administrative products with finance, asset, compliance and case management capabilities that run government agencies more efficiently. As the market driver for advancing safety and justice with innovative technology, CentralSquare serves 3 out of 4 citizens across North America. The company is headquartered in Lake Mary, FL and has locations in North Carolina, South Dakota and British Columbia. More information is available at CentralSquare.com.

EMERGING TECHNOLOGY

Surfacide® Awarded U.S. General Services Administration (GSA) Contract

Surfacide | March 20, 2023

Surfacide, an industry leader in UV-C low-level disinfection technology, announced today that it has been awarded a Multiple Award Schedule (MAS) contract by the U.S. General Services Administration (GSA). This contract will allow government customers and federal agencies to easily procure Surfacide's Helios® UV-C disinfection systems for their healthcare facilities. As a GSA Schedule Contractor, Surfacide has met all the requirements to sell to the federal government, making the federal purchasing process faster and more cost-effective for government agencies. Government buyers will now be able to access Surfacide products through GSA Advantage!, the government's premier online shopping superstore. The Surfacide Helios system is the only patented, low-level UV-C disinfection solution to use a trio of light emitting 'robots' simultaneously, significantly reducing bacteria and virus on colonized surfaces. The Helios system provides UV-C energy to more exposed areas than single devices—boosting power, dosage and efficacy in a single cycle. The system can be easily moved and configured within different high-impact areas of a hospital or clinic such as patient rooms, patient bathrooms, ORs, outpatient/ambulatory surgery, burn units, labor & delivery, isolation rooms, etc. "As a GSA Schedule Contractor, we now have the stamp of approval stating that we've met all the requirements to sell to the federal government, giving us a huge benefit in the federal purchasing process," said Gunner Lyslo, CEO & Founder of Surfacide. "We're proud to have been awarded this GSA MAS contract and are excited to provide our innovative UV-C disinfection technology to government customers more efficiently." Surfacide is rapidly growing and has become widely adopted in the VA space. After seeing the benefits of Surfacide's scientifically-proven technology, more and more VA facilities are transitioning from single emitters to Surfacide's patented triple-emitter Helios System. About Surfacide Founded in 2010, Surfacide is a UV technology and infection solutions company producing scientifically proven, hospital-grade UV devices. Surfacide's award-winning Helios® System is the world's only patented, triple emitter 'robotic' UV light solution to rapidly reduce bioburden and pathogens. A trusted partner in infection prevention, Surfacide has been deployed in over 600 leading hospitals, nursing homes, dental offices, fire stations, prisons, police stations, commercial office spaces, hotels and public venues worldwide. Surfacide LLC is proud to be American-made and manufactured in Waukesha, WI.